Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01XMK
|
|||
| Former ID |
DNC013373
|
|||
| Drug Name |
2-(3-(2-methylquinolin-7-yl)phenyl)acetonitrile
|
|||
| Synonyms |
CHEMBL267839; 2-(3-(2-methylquinolin-7-yl)phenyl)acetonitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H14N2
|
|||
| Canonical SMILES |
CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC(=C3)CC#N
|
|||
| InChI |
1S/C18H14N2/c1-13-5-6-15-7-8-17(12-18(15)20-13)16-4-2-3-14(11-16)9-10-19/h2-8,11-12H,9H2,1H3
|
|||
| InChIKey |
XNAOGJHXZYYKMV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4415-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.